This study sought to report the incidence of device-related thrombosis (DRT) and thromboembolic (TE) events when an alternative to clopidogrel is prescribed in loss-of-function (LOF) allele carriers of the cytochrome P450 2C19 (CYP2C19) gene.
Incidence of device-related thrombosis in watchman patients undergoing a genotype-guided antithrombotic strategy / Della Rocca, Domenico G; Horton, Rodney P; Di Biase, Luigi; Gianni, Carola; Trivedi, Chintan; Mohanty, Sanghamitra; Anannab, Alisara; Magnocavallo, Michele; Chen, Qiong; Tarantino, Nicola; Bassiouny, Mohamed; Lavalle, Carlo; Natale, Veronica N; Forleo, Giovanni B; Del Prete, Armando; Van Niekerk, Christoffel Johannes; Al-Ahmad, Amin; Burkhardt, J David; Gallinghouse, G Joseph; Sanchez, Javier E; Lakkireddy, Dhanunjaya; Gibson, Douglas N; Natale, Andrea. - In: JACC. CLINICAL ELECTROPHYSIOLOGY. - ISSN 2405-500X. - 7:12(2021), pp. 1533-1543. [10.1016/j.jacep.2021.04.012]
Incidence of device-related thrombosis in watchman patients undergoing a genotype-guided antithrombotic strategy
Magnocavallo, Michele;Lavalle, Carlo;
2021
Abstract
This study sought to report the incidence of device-related thrombosis (DRT) and thromboembolic (TE) events when an alternative to clopidogrel is prescribed in loss-of-function (LOF) allele carriers of the cytochrome P450 2C19 (CYP2C19) gene.| File | Dimensione | Formato | |
|---|---|---|---|
|
DellaRocca_Incindence_2021.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
1.44 MB
Formato
Adobe PDF
|
1.44 MB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
